ArticleTherapeutic advances in endocrinology and metabolism2018

Use of dapagliflozin as an add-on to insulin therapy in patients with suboptimally controlled type 2 diabetes.

Gautam Das et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.